THE MANAGEMENT OF NAUSEA AND VOMITING IN CLINICAL ONCOLOGY

被引：88
作者：
CRAIG, JB [1 ]
POWELL, BL [1 ]
机构：
[1] WAKE FOREST UNIV,BOWMAN GRAY SCH MED,DEPT MED,ONCOL RES CTR,WINSTON SALEM,NC 27103
来源：
AMERICAN JOURNAL OF THE MEDICAL SCIENCES | 1987年 / 293卷 / 01期
关键词：
D O I：
10.1097/00000441-198701000-00008
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：34 / 44
页数：11
相关论文
共 89 条
[1]  
AAPRO MS, 1981, CANCER CHEMOTH PHARM, V7, P11
[2]   METOCLOPRAMIDE - PHARMACOLOGY AND CLINICAL-APPLICATION [J].
ALBIBI, R ;
MCCALLUM, RW .
ANNALS OF INTERNAL MEDICINE, 1983, 98 (01) :86-95
[3]   METOCLOPRAMIDE - DOSE-RELATED TOXICITY AND PRELIMINARY ANTIEMETIC STUDIES IN CHILDREN RECEIVING CANCER-CHEMOTHERAPY [J].
ALLEN, JC ;
GRALLA, R ;
REILLY, L ;
KELLICK, M ;
YOUNG, C .
JOURNAL OF CLINICAL ONCOLOGY, 1985, 3 (08) :1136-1141
[4]  
ALLEN S, 1984, P ASCO, V3, P89
[5]  
ANTHONY L, 1985, J CLIN ONCOL, V4, P98
[6]  
Artim R, 1983, P AN M AM SOC CLIN, V2, P85
[7]   ADVANCES IN ANTI-EMETIC THERAPY [J].
BAKOWSKI, MT .
CANCER TREATMENT REVIEWS, 1984, 11 (03) :237-256
[8]   LORAZEPAM - A RANDOMIZED, DOUBLE-BLIND, CROSSOVER STUDY OF A NEW ANTIEMETIC IN PATIENTS RECEIVING CYTO-TOXIC CHEMOTHERAPY AND PROCHLORPERAZINE [J].
BISHOP, JF ;
OLVER, IN ;
WOLF, MM ;
MATTHEWS, JP ;
LONG, M ;
BINGHAM, J ;
HILLCOAT, BL ;
COOPER, IA .
JOURNAL OF CLINICAL ONCOLOGY, 1984, 2 (06) :691-695
[9]   AREA POSTREMA - CHEMORECEPTOR TRIGGER ZONE FOR VOMITING - IS THAT ALL [J].
BORISON, HL .
LIFE SCIENCES, 1974, 14 (10) :1807-1817
[10]  
BORISON HL, 1953, PHARMACOL REV, V5, P193
123456789